Olanzapine + Placebo

ApprovedCompleted

0 views this week 0 watching⚡ Active

Interest: 43/100

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

✓

Phase 3

Approved

Indication / Disease

Bipolar Disorder

Conditions

Bipolar Disorder, Depression, Depressive Disorder

Trial Timeline

Oct 1, 2007 → May 1, 2009

NCT ID

NCT00520507

About Olanzapine + Placebo

Olanzapine + Placebo is a approved stage product being developed by Eli Lilly for Bipolar Disorder. The current trial status is completed. This product is registered under clinical trial identifier NCT00520507. Target conditions include Bipolar Disorder, Depression, Depressive Disorder.

What happened to similar drugs?

20 of 20 similar drugs in Bipolar Disorder were approved

Approved (20) Terminated (3) Active (0)

✅OlanzapineEli LillyApproved

✅olanzapine + divalproex sodium + placeboEli LillyApproved

✅olanzapine + risperidoneEli LillyApproved

✅Topiramate + PlaceboEli LillyApproved

✅Olanzapine Fluoxetine Combination (OFC) + PlaceboEli LillyApproved

✅Olanzapine + Fluoxetine + LamotrigineEli LillyApproved

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (6)

NCT ID	Phase	Status	Start	Completion	Indication
NCT00520507	Approved	Completed	Oct 1, 2007	May 1, 2009	Bipolar Disorder
NCT00510146	Phase 3	Completed	Aug 1, 2007	Jul 1, 2010	Depression, Bipolar
NCT00091650	Phase 3	Completed	Mar 1, 2004	Nov 1, 2005	Borderline Personality Disorder
NCT00051298	Phase 3	Completed	Nov 1, 2002	Apr 1, 2005	Schizophrenia
NCT00050206	Approved	Completed	Nov 1, 2002	May 1, 2005	Bipolar Disorder
NCT00592930	Approved	Completed	Jun 1, 2000	Dec 1, 2004	Anorexia Nervosa

Competing Products

20 competing products in Bipolar Disorder

See all competitors

Product	Company	Stage	Hype Score
Olanzapine	Eli Lilly	Phase 3	32
Valproate + Lithium + Risperidone + Olanzapine	Eli Lilly	Phase 3	40
FK949E	Astellas Pharma	Phase 3	40
FK949E	Astellas Pharma	Phase 3	40
FK949E + Placebo	Astellas Pharma	Phase 2/3	38
Escitalopram + Bupropion XL	Lupin Limited	Phase 3	32
Olanzapine	Eli Lilly	Approved	43
Olanzapine Hydrochloride + Lithium Carbonate	Eli Lilly	Phase 3	40
olanzapine + lithium + valproate + carbamazepine	Eli Lilly	Phase 3	40
Olanzapine	Eli Lilly	Approved	43
Olanzapine	Eli Lilly	Phase 3	40
LY2979165 + Placebo	Eli Lilly	Phase 1	29
olanzapine + divalproex sodium + placebo	Eli Lilly	Approved	43
olanzapine + risperidone	Eli Lilly	Approved	43
LY2979165 + placebo	Eli Lilly	Phase 1	29
Topiramate + Placebo	Eli Lilly	Approved	43
olanzapine	Eli Lilly	Phase 3	40
Olanzapine + Placebo	Eli Lilly	Phase 3	40
Brenipatide + Placebo	Eli Lilly	Phase 2	42
Olanzapine Fluoxetine Combination (OFC) + Placebo	Eli Lilly	Approved	43